Skandinaviska Enskilda Banken Ab (Publ) United Therapeutics Corp Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.6 Billion
- Q4 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in United Therapeutics Corp stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 84,005 shares of UTHR stock, worth $31.1 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
84,005
Previous 94,773
11.36%
Holding current value
$31.1 Million
Previous $34 Million
12.72%
% of portfolio
0.14%
Previous 0.16%
Shares
27 transactions
Others Institutions Holding UTHR
# of Institutions
719Shares Held
60.7MCall Options Held
181KPut Options Held
158K-
Wealthfront Advisers LLC18.3MShares$6.79 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$2.03 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.65 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$1.02 Billion14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$913 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.9B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...